Attenuation of cigarette smoke-induced airway mucus production by hydrogen-rich saline in rats
Yunye Ning, Yan Shang, Haidong Huang, Jingxi Zhang, Yuchao Dong, Wujian Xu, Qiang Li, Yunye Ning, Yan Shang, Haidong Huang, Jingxi Zhang, Yuchao Dong, Wujian Xu, Qiang Li
Abstract
Background: Over-production of mucus is an important pathophysiological feature in chronic airway disease such as chronic obstructive pulmonary disease (COPD) and asthma. Cigarette smoking (CS) is the leading cause of COPD. Oxidative stress plays a key role in CS-induced airway abnormal mucus production. Hydrogen protected cells and tissues against oxidative damage by scavenging hydroxyl radicals. In the present study we investigated the effect of hydrogen on CS-induced mucus production in rats.
Methods: Male Sprague-Dawley rats were divided into four groups: sham control, CS group, hydrogen-rich saline pretreatment group and hydrogen-rich saline control group. Lung morphology and tissue biochemical changes were determined by immunohistochemistry, Alcian Blue/periodic acid-Schiff staining, TUNEL, western blot and realtime RT-PCR.
Results: Hydrogen-rich saline pretreatment attenuated CS-induced mucus accumulation in the bronchiolar lumen, goblet cell hyperplasia, muc5ac over-expression and abnormal cell apoptosis in the airway epithelium as well as malondialdehyde increase in the BALF. The phosphorylation of EGFR at Tyr1068 and Nrf2 up-regulation expression in the rat lungs challenged by CS exposure were also abrogated by hydrogen-rich saline.
Conclusion: Hydrogen-rich saline pretreatment ameliorated CS-induced airway mucus production and airway epithelium damage in rats. The protective role of hydrogen on CS-exposed rat lungs was achieved at least partly by its free radical scavenging ability. This is the first report to demonstrate that intraperitoneal administration of hydrogen-rich saline protected rat airways against CS damage and it could be promising in treating abnormal airway mucus production in COPD.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
References
- Barnes PJ (2007) Chronic obstructive pulmonary disease: a growing but neglected global epidemic. PLoS Med 4: e112.
- Fahy JV, Dickey BF (2010) Airway mucus function and dysfunction. N Engl J Med 363: 2233–2247.
- Burgel PR, Martin C (2010) Mucus hypersecretion in COPD: should we only rely on symptoms? European Respiratory Review 19: 94–96.
- Sivaprasad U, Askew D, Ericksen M, Gibson A, Stier M, et al... (2010) A non-redundant role for Serpinb3a in the induction of mucus production in asthma. J Immunol 184: 141.117–.
- MacNee W (2005) Pulmonary and Systemic Oxidant/Antioxidant Imbalance in Chronic Obstructive Pulmonary Disease. Proceedings of the ATS 2: 50–60.
- Repine J, Bast A, Lankhorst IDA (1997) The Oxidative Stress Study Group (1997) Oxidative Stress in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 156: 341–357.
- Malhotra D, Thimmulappa R, Navas-Acien A, Sandford A, Elliott M, et al. (2008) Decline in NRF2-regulated Antioxidants in Chronic Obstructive Pulmonary Disease Lungs Due to Loss of Its Positive Regulator, DJ-1. Am J Respir Crit Care Med 178: 592–604.
- MacNee W, Rahman I (1999) Oxidants and Antioxidants as Therapeutic Targets in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 160: S58–65.
- Sadowska AM (2012) N-Acetylcysteine mucolysis in the management of chronic obstructive pulmonary disease. Therapeutic Advances in Respiratory Disease 6: 127–135.
- Nakao A, Sugimoto R, Billiar TR, McCurry KR (2009) Therapeutic antioxidant medical gas. J Clin Biochem Nutr 44: 1–13.
- Hardeland R (2012) Hydrogen therapy: a future option in critical care? Crit Care Med 40: 1382–1383.
- Huang CS, Kawamura T, Toyoda Y, Nakao A (2010) Recent advances in hydrogen research as a therapeutic medical gas. Free Radic Res 44: 971–982.
- Liu SL, Liu K, Sun Q, Liu WW, Tao HY, et al. (2011) Hydrogen Therapy may be a Novel and Effective Treatment for COPD. Front Pharmacol 2: 19.
- Mannino DM, Buist AS (2007) Global burden of COPD: risk factors, prevalence, and future trends. Lancet 370: 765–773.
- Stevenson CS, Coote K, Webster R, Johnston H, Atherton HC, et al. (2005) Characterization of cigarette smoke-induced inflammatory and mucus hypersecretory changes in rat lung and the role of CXCR2 ligands in mediating this effect. Am J Physiol Lung Cell Mol Physiol 288(3): L514–522.
- Ohsawa I, Ishikawa M, Takahashi K, Watanabe M, Nishimaki K, et al. (2007) Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med 13: 688–694.
- Chen L, Sun BB, Wang T, Wang X, Li JQ, et al. (2010) Cigarette smoke enhances β-defensin 2 expression in rat airways via nuclear factor-κ B activation. European Respiratory Journal 36: 638–645.
- Sun Q, Cai J, Liu S, Liu Y, Xu W, et al. (2011) Hydrogen-rich saline provides protection against hyperoxic lung injury. J Surg Res 165: e43–49.
- Curran DR, Cohn L (2010) Advances in Mucous Cell Metaplasia: A Plug for Mucus as a Therapeutic Focus in Chronic Airway Disease. Am J Respir Cell Mol Biol 42: 268–275.
- Voynow JA, Gendler SJ, Rose MC (2006) Regulation of Mucin Genes in Chronic Inflammatory Airway Diseases. Am J Respir Cell Mol Biol 34: 661–665.
- Shimizu T, Hirano H, Shimizu S, Kishioka C, Sakakura Y, et al. (2001) Differential Properties of Mucous Glycoproteins in Rat Nasal Epithelium. A Comparison between Allergic Inflammation and Lipopolysaccharide Stimulation. Am J Respir Crit Care Med 164: 1077–1082.
- Perez-Vilar J, Mabolo R, McVaugh CT, Bertozzi CR, Boucher RC (2006) Mucin Granule Intraluminal Organization in Living Mucous/Goblet Cells: ROLES OF PROTEIN POST-TRANSLATIONAL MODIFICATIONS AND SECRETION. J Biol Chem 281: 4844–4855.
- D'Agostini F, Balansky RM, Izzotti A, Lubet RA, Kelloff GJ, et al. (2001) Modulation of apoptosis by cigarette smoke and cancer chemopreventive agents in the respiratory tract of rats. Carcinogenesis 22(3): 375–380.
- Lin JL, Thomas PS (2010) Current perspectives of oxidative stress and its measurement in chronic obstructive pulmonary disease. COPD 7(4): 291–306.
- Rahman I, van Schadewijk AAM, Crowther AJL, Hiemstra PS, Stolk J, et al. (2002) 4-Hydroxy-2-Nonenal, a Specific Lipid Peroxidation Product, Is Elevated in Lungs of Patients with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 166: 490–495.
- Kajiyama S, Hasegawa G, Asano M, Hosoda H, Fukui M, et al. (2008) Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Nutr Res 28: 137–143.
- Nakao A, Toyoda Y, Sharma P, Evans M, Guthrie N (2010) Effectiveness of hydrogen rich water on antioxidant status of subjects with potential metabolic syndrome-an open label pilot study. J Clin Biochem Nutr 46: 140–149.
- Yageta Y, Ishii Y, Morishima Y, Masuko H, Ano S, et al. (2011) Role of Nrf2 in Host Defense against Influenza Virus in Cigarette Smoke-Exposed Mice. J Virol 85: 4679–4690.
- Casalino-Matsuda SM, Monzon ME, Forteza RM (2006) Epidermal Growth Factor Receptor Activation by Epidermal Growth Factor Mediates Oxidant-Induced Goblet Cell Metaplasia in Human Airway Epithelium. Am J Respir Cell Mol Biol 34: 581–591.
- Hayashida K, Sano M, Ohsawa I, Shinmura K, Tamaki K, et al. (2008) Inhalation of hydrogen gas reduces infarct size in the rat model of myocardial ischemia-reperfusion injury. Biochem Biophys Res Commun 373: 30–35.
Source: PubMed